Featured News
Press Release
Alzheimer’s Association Statement on European Medicines Agency Negative Opinion on Leqembi for the Treatment of Alzheimer’s Disease
CHICAGO, July 26, 2024 — The Alzheimer’s Association is disappointed by today’s decision by the European Medicines Agency (EMA) to recommend against allowing Leqembi® to be marketed across the Eu...
All News
AIM Blog
Recognizing AIM’s December Advocate of the Month: Dean Brenner
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Alzheimer’s Association Mourns Death of Former Supreme Court Justice Sandra Day O'Connor
CHICAGO, Dec. 1, 2023 — The Alzheimer’s Association is saddened by the death of former Supreme Court Justice Sandra Day...
AIM Blog
Recognizing Native American Heritage Month
The population of older American Indians and Alaska Natives is growing quickly, leading to an increased risk for Alzheimer’s and...
AIM Blog
Building Momentum in Alzheimer’s and Dementia Research
Thanks to our dedicated advocates and bipartisan congressional champions, AIM has helped usher in a new phase of progress in...
AIM Blog
Raising Awareness of Alzheimer’s Policy Priorities in Every Election
Every election matters. While political pundits may be already focused on 2024, Americans voters will choose many of their critical...
AIM Blog
Recognizing AIM’s November Advocate of the Month: Bonnie Farmer Hay
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...